1-7 of 7
Marjorie Robbins
Close
Save search
Sort by
Journal Articles

Phase 1b Study of IDH Inhibition with Enasidenib and MEK Inhibition with Cobimetinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Who Have Co-Occurring IDH2 and RAS Signaling Gene Mutations

Free
Brian J. Ball, Jianying Zhang, Michelle Afkhami, Marjorie Robbins, Lauren Chang, Samantha Humpal, Vania Porras, Yilun Liu, Tim W Synold, Sarah Farzinkhou, Azra Borogovac, Paul B. Koller, Hoda Pourhassan, Vaibhav Agrawal, Anthony S. Stein, Mary-Elizabeth M. Percival, Alexey V. Danilov, Guido Marcucci
Journal: Blood
Blood (2024) 144 (Supplement 1): 6043.
https://doi.org/10.1182/blood-2024-211652
Published: 2024
Journal Articles

Phase 1 Trial of Navitoclax/Venetoclax/Decitabine Combination in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Free
Anthony S. Stein, Jianying Zhang, Lucy Y. Ghoda, Marjorie Robbins, Cindy Croslin, Banafsheh Sinaki, Ahmed Aribi, Amanda Blackmon, Hoda Pourhassan, Brian J. Ball, Ibrahim Aldoss, Ryotaro Nakamura, MHD Monzr M. Al Malki, Karamjeet S Sandhu, Guido Marcucci
Journal: Blood
Blood (2024) 144 (Supplement 1): 4264.
https://doi.org/10.1182/blood-2024-205980
Published: 2024
Journal Articles

A Phase 1 Study of Venetoclax in Combination with a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed Adults with B-Cell Ph-like ALL

Free
Ibrahim Aldoss, Jianying Zhang, Marjorie Robbins, Vaibhav Agrawal, Ahmed Aribi, Hoda Pourhassan, Paul B. Koller, Amanda Blackmon, Karamjeet S. Sandhu, Haris Ali, Brian J. Ball, Andrew Artz, Monzr M. Al Malki, Amandeep Salhotra, Zhaohui Gu, Asucena Leon Beltran, Christina Lai, Michelle Afkhami, Lucy Y. Ghoda, Stephen J. Forman, Guido Marcucci, Anthony Stein, Vinod Pullarkat
Journal: Blood
Blood (2023) 142 (Supplement 1): 2870.
https://doi.org/10.1182/blood-2023-187469
Published: 2023
Journal Articles

Pharmacology of a CpG-Linked Anti-Mir-126 Oligonucleotide Targeting Acute Myeloid Leukemia (AML) in Rats and Non-Human Primates (NHP)

Free
Lucy Ghoda, Kokilah Muthaiyah, Bin Amber Zhang, Marcin Kortylewski, James Simpson, Le Xuan Truong Nguyen, Marjorie Robbins, Guido Marcucci, Tim Synold
Journal: Blood
Blood (2023) 142 (Supplement 1): 5754.
https://doi.org/10.1182/blood-2023-191202
Published: 2023
Journal Articles

A Phase 1b Study of IDH Inhibition with Enasidenib and MEK Inhibition with Cobimetinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Who Have Co-Occurring IDH2 and RAS Signaling Gene Mutations

Free
Brian J Ball, Eytan Stein, Marjorie Robbins, Jianying Zhang, Ross L. Levine, Timothy Synold, Anthony S. Stein, Guido Marcucci, Yilun Liu, Alexey V Danilov
Journal: Blood
Blood (2022) 140 (Supplement 1): 11761–11762.
https://doi.org/10.1182/blood-2022-170820
Published: 2022
Journal Articles

Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Free
Vaibhav Agrawal, Cindy Croslin, Asuscena L. Beltran, Jianying Zhang, Joycelynne Palmer, Quy Huynh-Tran, Rochelle Hernandez, Sandra Thomas, Marjorie Robbins, Ahmed Aribi, Haris Ali, Anthony S. Stein, Elizabeth L. Budde, Monzr M. Al Malki, Guido Marcucci
Journal: Blood
Blood (2022) 140 (Supplement 1): 6235–6236.
https://doi.org/10.1182/blood-2022-165894
Published: 2022
Journal Articles

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL

Free
Karamjeet S. Sandhu, Alan Macias, Marissa Del Real, Asuscena L. Beltran, Young Sun Kim, Jianying Zhang, Joycelynne Palmer, Marjorie Robbins, Reyna Loomis, Mojtaba Akhtari, Ahmed Aribi, Shukaib Arslan, Amandeep Salhotra, Matthew Mei, Hoda Pourhassan, Paul B. Koller, Idoroenyi Amanam, Vaibhav Agrawal, Peter T. Curtin, Ricardo Spielberger, Vinod A. Pullarkat, Ibrahim Aldoss, F. Mark Stewart, Eileen P. Smith, Stephen J Forman, Anthony S. Stein, Guido Marcucci, L. Elizabeth Budde
Journal: Blood
Blood (2022) 140 (Supplement 1): 8985–8986.
https://doi.org/10.1182/blood-2022-170279
Published: 2022